Sunshine Biopharma (SBFM) Total Current Liabilities (2015 - 2026)
Sunshine Biopharma's (SBFM) quarterly Total Current Liabilities came in at $5.9 million in Q1 2026, up 2.01% YoY from $5.8 million in Q1 2025, and down 8.78% on a QoQ basis from $6.4 million in Q4 2025.
Sunshine Biopharma (SBFM) Total Current Liabilities (2015 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 12 years of Total Current Liabilities data on file, last reported at $5.9 million in Q1 2026.
- Quarterly Total Current Liabilities rose 2.01% year-over-year to $5.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.9 million (up 2.01% YoY) and the FY2025 annual result came in at $6.4 million, up 2.04% from the prior year.
- Total Current Liabilities slipped to $5.9 million in Q1 2026, from $6.4 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $6.9 million in Q4 2022 to a low of $95234.0 in Q1 2022.
- A 5-year average of $4.9 million and a median of $5.6 million in 2025 frame the typical range for Total Current Liabilities.
- The widest YoY moves for Total Current Liabilities: up 7497.38% in 2022, down 88.99% in 2022.
- Tracing SBFM's Total Current Liabilities over 5 years: stood at $6.9 million in 2022, then declined by 19.9% to $5.6 million in 2023, then gained by 13.74% to $6.3 million in 2024, then gained by 2.04% to $6.4 million in 2025, then fell by 8.78% to $5.9 million in 2026.
- The last three Total Current Liabilities figures came in at $5.9 million (Q1 2026), $6.4 million (Q4 2025), and $6.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.11 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 43.11 Bn | 39.45 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.53 Bn | 22.73 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.47 Bn | 19.81 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.66 Bn | 17.77 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.98 Bn | 11.45 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.08 Bn | 9.91 Bn | - | 1.79 Bn |
| 10 | Sunshine Biopharma | 1.57 Mn | -12.18 Mn | 2.43 Mn | 5.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.62 Mn |
| Mar 31, 2026 | 5.88 Mn |
| Dec 31, 2025 | 6.44 Mn |
| Sep 30, 2025 | 6.65 Mn |
| Jun 30, 2025 | 5.57 Mn |
| Mar 31, 2025 | 5.76 Mn |
| Dec 31, 2024 | 6.31 Mn |
| Sep 30, 2024 | 4.53 Mn |
| Jun 30, 2024 | 5.30 Mn |
| Mar 31, 2024 | 6.53 Mn |
| Dec 31, 2023 | 5.55 Mn |
| Sep 30, 2023 | 5.09 Mn |
| Jun 30, 2023 | 4.66 Mn |
| Mar 31, 2023 | 6.91 Mn |
| Dec 31, 2022 | 6.93 Mn |
| Sep 30, 2022 | 480,209.00 |
| Jun 30, 2022 | 104,684.00 |
| Mar 31, 2022 | 95,234.00 |
| Dec 31, 2021 | 91,229.00 |
| Sep 30, 2021 | 471,632.00 |